Clinical Trial Update: Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atorvastatin for prevention of atrial fibrillation; the study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Emory University | Conditions: Atrial Fibrillation, Inflammation | Phase 3 | Status: TERMINATED | Results posted: 2014-09-03